What is Janux Therapeutics's net investment in lease?

Janux Therapeutics (JANX) reported net investment in lease of $17.87M in Q1 2026.

How has Janux Therapeutics's net investment in lease changed year-over-year?

Janux Therapeutics's net investment in lease decreased by 5.3% year-over-year, from $18.88M to $17.87M.

Janux Therapeutics JANX Net Investment in Lease

Net Investment in Lease at other companies

XencorXNCR

——

Vor BiopharmaVOR

——

Cullinan Therapeutics, Inc.CGEM

——

ImmunomeIMNM

——

CRISPR TherapeuticsCRSP

——

Inhibrx Biosciences, Inc.INBX

——

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

P/S65×-84.6×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's net investment in lease?: Janux Therapeutics (JANX) reported net investment in lease of $17.87M in Q1 2026.
How has Janux Therapeutics's net investment in lease changed year-over-year?: Janux Therapeutics's net investment in lease decreased by 5.3% year-over-year, from $18.88M to $17.87M.